Prevalence of antinuclear antibodies in hidradenitis suppurativa.

Shaunak MulaniSean McNishDerek JonesVictoria K Shanmugam

Published in: International journal of rheumatic diseases (2018)

The prevalence of baseline ANA positivity in this HS population was similar to that seen in the general population (5.4%). The rate of seroconversion and drug-induced complications in this population were low.

Keyphrases

drug induced
liver injury
risk factors
hidradenitis suppurativa
adverse drug